Cytidine 5′-diphosphocholine sodium salt dihydrate
SIGMA/C0256 - ~98%, from yeast, solid
Synonym: CDP-choline-Na; CDP-coline; Citicoline sodium; P′-[2-(Trimethylammonio)ethyl]ester cytidine 5′-(trihydrogen diphosphate) inner salt monosodium
CAS Number: 33818-15-4
Empirical Formula (Hill Notation): C14H25N4NaO11P2 · 2H2O
Molecular Weight: 546.34
MDL Number: MFCD00150508
Linear Formula: C14H25N4NaO11P2 · 2H2O
Product Type: Chemical
| assay | ~98% |
| biological source | yeast |
| color | white |
| form | solid |
| InChI | 1S/C14H26N4O11P2.Na/c1-18 |
| InChI key | YWAFNFGRBBBSPD-MBWJOHGMSA |
| Quality Level | 200 ![]() |
| SMILES string | [Na+].C[N+](C)(C)CCOP([O- |
| solubility | H2O: 100 mg/mL |
| storage temp. | −20°C |
| Application: | Cytidine 5′-diphosphocholine sodium salt dihydrate has been used as a physiological metabolite for the identification of gemcitabine diphosphate choline (GdPC) by liquid chromatography-mass spectrometry (LC-MS/MS) method in the Kennedy pathway . |
| Biochem/physiol Actions: | Cytidine 5′-diphosphocholine (CDP-choline) plays an important role in the synthesis of phosphatidylcholine. It is also involved in the biosynthesis of acetylcholine, a neurotransmitter. CDP-choline has therapeutic effects against hypoxia, cerebral ischemia and traumatic brain injury. It also exhibits therapeutic effects against learning and memory disorders, drug addiction and Alzheimer′s and Parkinson′s diseases. |
| Disclaimer: | Hygroscopic |
| General description: | Cytidine 5′-diphosphocholine (CDP-choline) contains cytidine and choline linked via a diphosphate bridge. |
| Packaging: | 1 g in poly bottle |
| Packaging: | 100, 500 mg in poly bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ~98% |
| Storage Temp. | −20°C |
| UNSPSC | 41106300 |

